Diet in the management of diabetes
PDF (Español (España))
xhtml (Español (España))


Diabetes Mellitus, Type 2
Sugar-Sweetened Beverages
Anti-Obesity Agents
insulin resistance

How to Cite

Aschner Montoya , P. (2022). Diet in the management of diabetes. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 9(4).


Currently, the word "diet" has acquired a negative connotation and has been replaced by others such as "diet", but its clinical interpretation as caloric restriction remains the key to the initial management of type 2 diabetes (T2DM), as demonstrated by the Direct study (1), which achieved remission in 46% of T2DM cases after the first year and 36% at the end of two years, through the initial prescription of a very low calorie diet (~ 800 kcal/day). Remission, then, was between 86 % and 70 % in those patients who lost ? 15 kg. Probably the failure to get people with DT2 to lose weight is one of the major forms of therapeutic inertia, leading to unnecessary escalation of antidiabetics to the point of seeing still obese people taking insulin.

It is estimated that more than 80% of people with T2DD debut with some degree of excess weight. At that point, their identification by a muscle mass index (BMI) ? 27 kg/m² mandates a structured intervention that should include anti-obesity or preferably dual-acting drugs (also antidiabetic). Excess visceral fat (waist circumference ? 94cm or ? 90cm in men and women, respectively) indicates a high degree of insulin resistance and lends a sense of urgency to intervention (because of the cardiovascular risk involved). Although BMI does not accurately reflect fat mass, as suggested by the authors in the article included in this issue (2), it is sufficient for clinical decision making. A method such as bioimpedance, with properly calibrated instruments, can be useful to assess changes in body fat with different interventions and to better understand their mechanisms of action.
PDF (Español (España))
xhtml (Español (España))


Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7:344-55.

Rosero R, González C, Polanco J, Eraso-Checa F. Identificación de variables antropométricas para la determinación del índice de masa grasa como herramienta diagnóstica en obesidad. Rev Colomb Endocrinol Diabet Metab. 2022;9(4):e769.

Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378:e34.

Sierra Umaña SF, Garcés Arias A, Salinas Mendoza S, Castillo Rodríguez CA, Álzate Granados JP. Consumo de azúcar y eventos cardiovasculares mayores: revisión sistemática. Rev Colomb Endocrinol Diabet Metab. 2022;9(4):e681.

Builes-Montaño CE, Lema-Pérez L, Monsalve-Arango LE, Naranjo-Cano MA, Sierra Duque CM, García-Tirado JF, et al. STUDIA: An application to support carbohydrate counting by simulating glucose dynamics. Rev Colomb Endocrinol Diabet Metab. 2022;9(4):e770.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2022 Revista Colombiana de Endocrinología, Diabetes & Metabolismo




Download data is not yet available.